Kyle Villaruz, DPM
Podiatrist · Grants Pass, ORNPI 1770079659
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (34.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Pylant Medical at 38.1% of the total. Reporting peaked in 2020 at $2,640 and has fallen 85.5% since, to $384 in 2025.
Across 57 payments — averaging $120.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$3K
- Stryker$2K
- Medical Device Business Services, Inc.$938
- Treace Medical Concepts, Inc.$295
- Integra Lifesciences Corporation$258
- Kerecis Limited$175
- plus $582 from 7 others
What the payments were for
- Grants$3856%
- Travel & lodging$1,83927%
- Food & beverage$2,30433%
- Education$2,35234%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 7 | $2,621 |
| Stryker | 19 | $2,012 |
| Medical Device Business Services, Inc. | 6 | $938 |
| Treace Medical Concepts, Inc. | 13 | $295 |
| Integra Lifesciences Corporation | 1 | $258 |
| Kerecis Limited | 1 | $175 |
| Paragon 28, Inc. | 2 | $165 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $165 |
| Melinta Therapeutics, LLC | 1 | $116 |
| Smith+Nephew | 3 | $73 |
| Wildwood Medical LLC | 1 | $26 |
| Johnson & Johnson | 1 | $24 |
| Hydrofera LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NONE$1,389
- CYTAL$517
- Kerecis Omega3 Wound$175
- Kerecis Omega3 Surgibind$175
- Kerecis Omega3 GraftGuide$175
- Kerecis Omega3 SurgiClose$175
- Product Portfolio$145
- AUGMENT INJECTABLE$135
- PERCUPLASTY TRAY$134
- Kimyrsa$116
How this compares
$6,880 in reported general payments places this provider in the 85th percentile of 74 podiatrist providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 36 | $1,124 |
| Gabapentin | 16 | $506 |
| Cephalexin | 15 | $116 |
| Meloxicam | 21 | $44 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Grants Pass
- John CastleGrants Pass$263
- Rick McClureMedford$133K
- Cyaandi DoveGrand Ronde$51K
- Stephen SchroederTigard$28K
- Colin MizuoHillsboro$18K
- Melinda NicholesPortland$15K
- Amanda KameryEugene$9K
- Peter PhamBeaverton$8K
- Liang-Chieh KoEugene$7K
- Lyndon JohansenPortland$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.